LOGGIC/FIREFLY-2: a phase 3, randomized trial of tovorafenib vs. chemotherapy in pediatric and young adult patients with newly diagnosed low-grade glioma harboring an activating RAF alteration

Cornelis M. van Tilburg, Olaf Witt, Sébastien Perreault et al.|BMC Cancer|2024

Cited by 66